Wegovy May Carry Higher Risk of Rare Eye Stroke, Study Finds
TL;DR
A FAERS-based analysis of over 30 million adverse-event reports suggests Wegovy has the strongest association with ischemic optic neuropathy among semaglutide drugs, with higher signals in men and at higher Wegovy doses. While cases are rare and causation isn’t proven, researchers call for urgent prospective studies as GLP-1 obesity drugs become more widely used.
- Wegovy linked to rare “eye stroke” that can cause sudden blindness ScienceDaily
- Parker Waichman LLP Files Lawsuit on behalf of Florida Resident Alleging Development of Irreversible Eye Condition, NAION, after taking Ozempic PR Newswire
- Small NAION Risk from GLP-1 Therapy Not Yet Worth Drug Discontinuation, Experts Say Review of Optometry
- Mounjaro NAION Lawsuit Claims Side Effects Led to Permanent Vision Loss AboutLawsuits.com
- Research shows potential side effects of a worldwide drug The Herald Insight
Want the full story? Read the original reporting
Read on ScienceDaily